This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

King Pharmaceuticals Buyout Investigated For Shareholders By Goldfarb Branham Law Firm LLP

Goldfarb Branham LLP is investigating whether the Board of Directors of King Pharmaceuticals (NYSE: KG) breached fiduciary duties to its shareholders by agreeing to sell the company to Pfizer for $14.25 per share. Concerned King Pharmaceuticals investors are urged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com to learn about their rights.

“Under this agreement, King Pharmaceuticals shareholders will receive $14.25 in cash for each share they own,” said securities lawyer Hamilton Lindley. “Our investigation is focused on the potential unfairness of the price to King Pharmaceutical shareholders and the process by which the board considered and approved the transaction. In fact, at least one analyst set a price target for company stock at $15.00 per share.”

Goldfarb Branham LLP pursues claims nationwide for shareholders in unfair buyouts. Lawyers at the firm have significant experience representing shareholders in over 100 securities cases. If you have any information about this transaction or questions about your rights as a King Pharmaceutical shareholder contact the firm at hlindley@goldfarbbranham.com or call 877-583-2855.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs